MarketScreener Homepage > Equities > London Stock Exchange > GlaxoSmithKline plc GSK GB0009252882

Report

Delayed London Stock Exchange - 01/22 11:35:06 am
1380.2	GBX		+1.13%

01/22

GlaxoSmithKline-Owned ViiV Healthcare Says US FDA Approved its HIV Drug Cabenuva

01/22

GLAXOSMITHKLINE : ViiV Healthcare announces FDA approval of Cabenuva (cabotegravir, rilpivirine), the first and only complete long-acting regimen for HIV treatment

01/22

MARKET CHATTER : Pfizer, BioNTech Reportedly Agree to Supply Vaccine for WHO-Backed Scheme for Poorer Countries

News

Press Releases

Official Publications

Sector news

MarketScreener Strategies

Communiqués de presse de la société GLAXOSMITHKLINE PLC

01/22	GLAXOSMITHKLINE : ViiV Healthcare announces FDA approval of Cabenuva (cabotegrav..	AQ
01/22	BIONDVAX PHARMACEUTICALS : Announces Appointment of Amir Reichman as New CEO	AQ
01/22	GLAXOSMITHKLINE : GSK - ViiV Healthcare announces FDA approval of Cabenuva, the ..	AQ
01/19	GLAXOSMITHKLINE : ViiV Healthcare and Chelsea and Westminster Hospital continue ..	AQ
01/19	GLAXOSMITHKLINE : GSK and Novartis announce collaboration to support scientific ..	PU
01/18	HIKMA PHARMACEUTICALS : provides update on generic Advair Diskus launch	AQ
01/14	GLAXOSMITHKLINE : Conference transcript PDF - 125.9KB	PU
01/13	GLAXOSMITHKLINE : ViiV Healthcare receives EU Marketing Authorisation for the fi..	PU
01/12	GLAXOSMITHKLINE : JP Morgan Conference presentation	PU
01/08	GLAXOSMITHKLINE : GSK, MMV filing for Kozenis (tafenoquine) in paediatric popula..	PU
2020	GLAXOSMITHKLINE : Morgan Stanley ESG Conference presentation PDF - 366.3KB	PU
2020	Vectura earns $11m milestone as Hikma receives US FDA approval for generic Ad..	AQ
2020	HIKMA PHARMACEUTICALS : launches generic Advair Diskus following FDA approval	AQ
2020	GLAXOSMITHKLINE : GSK and Ahren Announce Co-Led Series A Investment in Adrestia,..	PU
2020	GLAXOSMITHKLINE : Vir Biotechnology and GSK announce start of NIH-sponsored ACTI..	PU
2020	GLAXOSMITHKLINE : FDA approves GSK's BENLYSTA as the first medicine for adult pa..	PU
2020	GLAXOSMITHKLINE : Sanofi and GSK announce a delay in their adjuvanted recombinan..	PU
2020	GLAXOSMITHKLINE : FDA accepts GSK's filing of Nucala (mepolizumab) for use in ch..	PU
2020	ViiV Healthcare and Shutterstock Studios unite to tackle outdated perceptions..	AQ
2020	GLAXOSMITHKLINE : ViiV Healthcare and the Medicines Patent Pool expand access to..	AQ
2020	GLAXOSMITHKLINE : GSK starts phase 3 study of RSV maternal candidate vaccine	AQ
2020	GLAXOSMITHKLINE : GSK starts phase 3 study of RSV maternal candidate vaccine	PU
2020	VECTURA : provides update on GSK litigation	AQ
2020	GLAXOSMITHKLINE : GSK and MMV present positive data on treatment for Plasmodium ..	PU
2020	GLAXOSMITHKLINE : ViiV Healthcare announces results of the PROgress study demons..	AQ
2020	GLAXOSMITHKLINE : ViiV Healthcare receives FDA Breakthrough Therapy Designation ..	AQ
2020	GLAXOSMITHKLINE : ViiV Healthcare receives FDA Breakthrough Therapy Designation ..	PU
2020	GLAXOSMITHKLINE : ViiV Healthcare announces CHMP positive opinion for the first-..	AQ
2020	GLAXOSMITHKLINE : GSK presents Phase 2b data on linerixibat for the treatment of..	PU
2020	GLAXOSMITHKLINE : ViiV Healthcare announces CHMP positive opinion for the first-..	PU
2020	GLAXOSMITHKLINE : Medicago and GSK announce start of Phase 2/3 clinical trials o..	PU
2020	GLAXOSMITHKLINE : ViiV Healthcare announces investigational injectable cabotegra..	AQ
2020	GLAXOSMITHKLINE : Horizon Therapeutics plc Names Karin Rosen, M.D., Ph.D. Execut..	AQ
2020	GLAXOSMITHKLINE : GSK sets new environmental goals of net zero impact on climate..	PU
2020	GLAXOSMITHKLINE : European Commission approves Zejula (niraparib) as first-line ..	PU
2020	GLAXOSMITHKLINE : GSK Nucala (mepolizumab) filings accepted by European Medicine..	PU
2020	GLAXOSMITHKLINE : Q3 2020 results transcript	PU
2020	GLAXOSMITHKLINE : Q3 2020 US Dollar Translation PDF - 155.1KB	PU
2020	GLAXOSMITHKLINE : Q3 2020 results slides PDF - 723.5KB	PU
2020	GLAXOSMITHKLINE : Q3 2020 Results Announcement PDF - 966.6KB	PU
2020	GLAXOSMITHKLINE : Q3 2020 Results Infographic PDF - 441.9KB	PU
2020	GLAXOSMITHKLINE : GSK delivers resilient performance, strong commercial executio..	PU
2020	GLAXOSMITHKLINE : Sanofi and GSK to support COVAX with 200 million doses of adju..	PU
2020	ANAPTYSBIO : and GlaxoSmithKline Amend Strategic Immuno-Oncology Collaboration	AQ
2020	GLAXOSMITHKLINE : GSK - ViiV Healthcare presents continued positive findings fro..	AQ
2020	Noveome Biotherapeutics, Inc. Announces New Appointments to its Board of Dire..	AQ
2020	GLAXOSMITHKLINE : ViiV Healthcare presents positive new findings from two studie..	PU
2020	GLAXOSMITHKLINE : ViiV Healthcare presents continued positive findings from firs..	PU
2020	GLAXOSMITHKLINE : ViiV Healthcare announces analysis showing no antiretroviral t..	PU
2020	GLAXOSMITHKLINE : GSK presents positive clinical data on maternal and older adul..	PU
2020	ViiV Healthcare receives positive CHMP opinion for long-acting regimen for th..	AQ
2020	GLAXOSMITHKLINE : ViiV Healthcare receives positive CHMP opinion for long-acting..	PU
2020	Enzymatica and STADA extend agreement on ViruProtect to Russia, Poland, Ukrai..	AQ
2020	GLAXOSMITHKLINE : Q3 2020 pre announcement aide memoire	PU
2020	GLAXOSMITHKLINE : ViiV Healthcare presents long-term switch data for Dovato demo..	PU
2020	GKN Aerospace leading smart manufacturing project to increase productivity	AQ
2020	VIR BIOTECHNOLOGY : and GSK announce global expansion to Phase 3 of COMET-ICE st..	AQ
2020	GLAXOSMITHKLINE : ViiV Healthcare announces dolutegravir plus lamivudine three-y..	PU
2020	GLAXOSMITHKLINE : ViiV Healthcare announces dolutegravir plus lamivudine three-y..	PU
2020	GLAXOSMITHKLINE : ViiV Healthcare to present long-term safety and efficacy data ..	PU
2020	GLAXOSMITHKLINE : FDA approves Nucala as the first and only biologic treatment f..	AQ
2020	GLAXOSMITHKLINE : Clover Announces Positive Preclinical Data and Updates on Phas..	AQ
2020	GLAXOSMITHKLINE : ViiV Healthcare announces start of implementation science stud..	PU
2020	GLAXOSMITHKLINE : FDA Approves Nucala as the First and Only Biologic Treatment f..	BU
2020	GLAXOSMITHKLINE : FDA approves Nucala as the first and only biologic treatment f..	PU
2020	PFIZER : ViiV Healthcare Announces Availability of CABENUVA and VOCABRIA in Cana..	AQ
2020	GLAXOSMITHKLINE : Sanofi and GSK sign agreements with the Government of Canada t..	PU
2020	GLAXOSMITHKLINE : GSK receives CHMP positive opinion recommending approval of Ze..	PU
2020	GLAXOSMITHKLINE : Sanofi and GSK confirm agreement with European Union to supply..	PU
2020	GLAXOSMITHKLINE : FDA approves Trelegy Ellipta as the first once-daily single in..	AQ
2020	GLAXOSMITHKLINE : FDA Approves Trelegy Ellipta as the First Once-Daily Single In..	BU
2020	GLAXOSMITHKLINE : FDA approves Trelegy Ellipta as the first once-daily single in..	PU
2020	AstraZeneca - Biopharma Leaders Unite to Stand With Science	AQ
2020	Biopharma Leaders Unite To Stand With Science	AQ
2020	Biopharma Leaders Unite To Stand With Science; Nine CEOs sign historic pledge..	AQ

1 2 3 4 5 6 7 8 9 10 Next

Analysis

Merck KGaA, GSK suffer lung cancer drug setback